1 week Ago By ABMN Staff
Custom Index Systems LLC acquired a new position in The Chemours Company ( NYSE:CC – Free Report ) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 17,620 shares of the specialty chemicals company’s stock, valued at approximately $398,000. Several other institutional investors have also recently modified their holdings of the company.
New Covenant Trust Company N.A. purchased a new position in Chemours in the 1st quarter worth $29,000.
Neo Ivy Capital Management purchased a new position in shares of Chemours in the fourth quarter worth about $40,000. North Star Investment Management Corp. lifted its stake in shares of Chemours by 1,510.
0% in the 1st quarter. North Star Investment Management Corp. now owns 1,288 shares of the specialty chemicals company’s stock valued at $34,000 after acquiring an additional 1,208 shares during the last quarter.
Sunbelt Securities Inc. boosted its holdings in Chemours by 1,969.7% during the 1st quarter.
Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock valued at $36,000 after acquiring an additional 1,300 shares during the period. Finally, Headlands Technologies LLC bought a new position in Chemours during the 1st quarter worth approximately $42,000.
76.26% of the stock is currently owned by institutional investors. Analyst Upgrades and Downgrades CC has been the subject of several recent research reports.
JPMorgan Chase & Co. lowered their price objective on Chemours from $25.00 to $18.
00 and set a “neutral” rating for the company in a research report on Tuesday, August 6th. The Goldman Sachs Group lowered their price target on shares of Chemours from $29.00 to $23.
00 and set a “neutral” rating for the company in a report on Tuesday, September 3rd. Mizuho began coverage on shares of Chemours in a report on Friday, June 7th. They issued a “neutral” rating and a $25.
00 price target on the stock. UBS Group lowered their price objective on shares of Chemours from $30.00 to $28.
00 and set a “buy” rating for the company in a research note on Tuesday, August 6th. Finally, BMO Capital Markets cut their target price on Chemours from $35.00 to $30.
00 and set an “outperform” rating on the stock in a research note on Tuesday, August 6th. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Chemours presently has an average rating of “Hold” and an average price target of $26.
75. Chemours Stock Performance Chemours stock opened at $17.47 on Monday.
The Chemours Company has a fifty-two week low of $15.10 and a fifty-two week high of $33.17.
The stock has a market cap of $2.60 billion, a price-to-earnings ratio of -8.05 and a beta of 1.
74. The stock’s 50 day simple moving average is $21.05 and its two-hundred day simple moving average is $24.
37. The company has a debt-to-equity ratio of 5.45, a quick ratio of 1.
01 and a current ratio of 1.89. Chemours ( NYSE:CC – Get Free Report ) last issued its quarterly earnings results on Thursday, August 1st.
The specialty chemicals company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.
19). The firm had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.
53 billion. Chemours had a return on equity of 33.21% and a net margin of 2.
16%. Chemours’s revenue for the quarter was down 6.4% on a year-over-year basis.
During the same period in the previous year, the company earned $1.10 earnings per share. As a group, analysts expect that The Chemours Company will post 1.
33 earnings per share for the current fiscal year. Chemours Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 15th will be given a dividend of $0.
25 per share. The ex-dividend date is Thursday, August 15th. This represents a $1.
00 dividend on an annualized basis and a yield of 5.72%. Chemours’s dividend payout ratio (DPR) is currently -46.
08%. Chemours Profile ( Free Report ) The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials.
The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. Recommended Stories Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company ( NYSE:CC – Free Report ).
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter ..
